Predicting Outcome and Therapy Response in mCRC Patients Using an Indirect Method for CTCs Detection by a Multigene Expression Panel: A Multicentric Prospective Validation Study.

Autor: Insua YV; Translational Medical Oncology, Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compostela, SERGAS Group, Trav. Choupana s/n, 15706 Santiago de Compostela, Spain. Yolanda.Vidal.Insua@sergas.es., Cámara J; Arquitecto Macide Hospital, SERGAS Group, Av. Residencia s/n, 15405 Ferrol, Spain. juan.cruz.de.la.camara.gomez@sergas.es., Vázquez EB; Translational Medical Oncology, Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compostela, SERGAS Group, Trav. Choupana s/n, 15706 Santiago de Compostela, Spain. elenambrozosv@hotmail.com., Fernández A; University Hospital of Ourense, SERGAS Group, Ramon Puga 54, 32005 Ourense, Spain. afm1003@hotmail.com., Rivera FV; Translational Medical Oncology, Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compostela, SERGAS Group, Trav. Choupana s/n, 15706 Santiago de Compostela, Spain. Francisca.Vazquez.Rivera@sergas.es., Silva MJVV; University Hospital of Vigo, SERGAS Group, Pizarro 22, 36204 Vigo, Spain. maria.jose.villanueva.silva@sergas.es., Barbazán J; Translational Medical Oncology, Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compostela, SERGAS Group, Trav. Choupana s/n, 15706 Santiago de Compostela, Spain. jorgebarbazan@gmail.com., Muinelo-Romay L; Translational Medical Oncology, Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compostela, SERGAS Group, Trav. Choupana s/n, 15706 Santiago de Compostela, Spain. lmuirom@gmail.com.; Liquid Biopsy Analysis Unit, Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compostela, SERGAS Group, Trav. Choupana s/n, 15706 Santiago de Compostela, Spain. lmuirom@gmail.com., Folgar SC; Translational Medical Oncology, Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compostela, SERGAS Group, Trav. Choupana s/n, 15706 Santiago de Compostela, Spain. soniasigueiro@yahoo.es., Abalo A; Translational Medical Oncology, Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compostela, SERGAS Group, Trav. Choupana s/n, 15706 Santiago de Compostela, Spain. alicia.abalo.pineiro@sergas.es.; Liquid Biopsy Analysis Unit, Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compostela, SERGAS Group, Trav. Choupana s/n, 15706 Santiago de Compostela, Spain. alicia.abalo.pineiro@sergas.es., López-López R; Translational Medical Oncology, Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compostela, SERGAS Group, Trav. Choupana s/n, 15706 Santiago de Compostela, Spain. Rafael.lopez.lopez@sergas.es., Abal M; Translational Medical Oncology, Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compostela, SERGAS Group, Trav. Choupana s/n, 15706 Santiago de Compostela, Spain. miguel.abal.posada@sergas.es., Alonso-Alconada L; Translational Medical Oncology, Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compostela, SERGAS Group, Trav. Choupana s/n, 15706 Santiago de Compostela, Spain. lorena.alonso.alconada@sergas.es.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2017 Jun 13; Vol. 18 (6). Date of Electronic Publication: 2017 Jun 13.